Adam Johnson is the founder of BullseyeBrief.com, an investment letter which explores American Ingenuity through actionable stock picks. Previously he anchored several daily programs at Bloomberg TV, interviewing CEOs, heads of state, and prominent investors. Mr. Johnson also traded stocks, options, and oil at ING Asset Management, Louis Dreyfus, and Merrill Lynch. He graduated from Princeton with a BA in economics.
If I told you that a company beat earnings estimates by 20%, posted revenue growth of 58% and raised forward guidance above consensus, would you be surprised if its stock plunged 34%? questions Adam Johnson, editor of Bullseye Brief.
We don’t often see the world’s best companies trade at a 50% discount to historic valuation despite beating estimates quarter after quarter… and we don’t often see investor sentiment imploding to a 30-year low, asserts Adam Johnson, editor of Bullseye Brief.
Rising interest rates have created significant headwinds for younger, small cap companies, so I have made a conscious pivot towards quality, asserts Adam Johnson, who serves as portfolio manager for the Adviser Investments American Ingenuity strategy; separately, he is the editor of the Bullseye Brief.
The world is pivoting to increasingly clean sources of energy, and highly visible companies like Amazon (AMZN) and FedEx (FDX) are increasingly turning to hydrogen fuel cells, explains Adam Johnson, growth stock specialist and editor of Bullseye Brief.
How we move is changing fast and it's not about building a faster Tesla. 30-ft drones transport US Air Force personnel across sprawling bases. Fuel cells power construction equipment, lifting thousands of pounds. Electric delivery vans make UPS greener and our air cleaner. Several pioneering companies are propelling the world forward at record speed. The question is which ones to buy today? Join Adam Johnson to discover how the future of mobility is now.
SpaceX made history with the launch into orbit of the first manned space capsule by a private company. While we may not be vacationing in Mars any time soon, we are living in a world where technology is evolving faster than ever. In this panel discussion, get up to speed on the latest trends in the industry, explore breakthrough technologies, and hear about the most innovative disruptors reshaping the future.
Tune in to this 30-minute session to discuss several Med-Tech hybrid companies as case studies, explaining how they're redefining health and moving the world forward. Adam Johnson is long on all of them, and see's significant upside. "Health Care's Holy Grail" is his biggest investment theme for 2021, thanks to the convergence of wearables, AI, 5G, and telemedicine, and he's excited to share with you what he has learned!
Biotechnology offers significant upside if you know where to look. Adam Johnson, founder of BullseyeBrief.com, shares his three favorite biotech stocks under $3, why he's long and what he expects. These are some of the best examples of American Ingenuity!